Contact:
Grayken Center for Addiction TTA
info@addictiontraining.org
– Minimize
Jump to event:
Addressing Alcohol and Methamphetamine Co-Use
Examining the Impact of Alcohol and MDMA
Addressing Alcohol and Caffeine Co-Use
+ Show events
Addressing Alcohol and Methamphetamine Co-Use
Monday, 12/22/25, 12:00 PM – 12:30 PM ET
Virtual event via Zoom
Credits available
Counts towards DEA's 8-hour training requirement
This training is designed for healthcare providers managing patients who use both alcohol and methamphetamines. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and methamphetamine consumption. The session emphasizes the mental health impacts of co-ingestion and examines how these effects influence clinical care. Participants will also review policy-level approaches that reduce associated risks and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and methamphetamine use disorders.
Show details
Virtual meeting
Via Zoom
Description
This training is designed for healthcare providers managing patients who use both alcohol and methamphetamines. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and methamphetamine consumption. The session emphasizes the mental health impacts of co-ingestion and examines how these effects influence clinical care. Participants will also review policy-level approaches that reduce associated risks and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and methamphetamine use disorders.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Justin Alves, MSN, FNP-BC, ACRN, CARN, CNE (he/him)Justin is a clinical nurse educator with Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance, a Family Nurse Practitioner in General Internal Medicine at BMC, and co-medical director of BMC’s Stimulant Treatment and Recovery Team (START) clinic. Justin earned a master’s in nursing from the University of Massachusetts-Dartmouth, a Post-Master's Family Nurse Practitioner certificate from the University of Massachusetts-Boston and is certified as a Certified Addiction Registered Nurse through the Addictions Nursing Certification Board.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Describe the prevalence and clinical significance of concurrent alcohol and methamphetamine use.
- Explain at least two physiological or behavioral health risks associated with alcohol and methamphetamine co-use.
- Identify at least two evidence-based strategies for treating co-occurring alcohol and methamphetamine use disorders.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 0.5 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 0.50 number of contact hours of which 0.25 are eligible for pharmacology credit.
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Hide details
Examining the Impact of Alcohol and MDMA
Monday, 12/29/25, 12:00 PM – 12:30 PM ET
Virtual event via Zoom
Credits available
Counts towards DEA's 8-hour training requirement
This training is designed for healthcare providers managing patients who use both alcohol and MDMA. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and MDMA consumption. The session will review emerging research on the use of MDMA as a potential treatment adjunct for alcohol use disorder (AUD). Participants will also examine policy-level approaches that reduce risks associated with co-use and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and MDMA-type use disorders.
Show details
Virtual meeting
Via Zoom
Description
This training is designed for healthcare providers managing patients who use both alcohol and MDMA. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and MDMA consumption. The session will review emerging research on the use of MDMA as a potential treatment adjunct for alcohol use disorder (AUD). Participants will also examine policy-level approaches that reduce risks associated with co-use and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and MDMA-type use disorders.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Vanessa Loukas, MSN, FNP-C, CARN-AP (she/her)Vanessa is a clinical nurse educator for Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance, a Family Nurse Practitioner in General Internal Medicine at BMC, and an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine. Vanessa earned her master’s in nursing from Simmons University and is certified as a Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Describe the spectrum and patterns of MDMA use among individuals with alcohol use disorder (AUD).
- Explain at least two physiological or behavioral health risks associated with co-occurring MDMA and alcohol use.
- Identify at least one intervention in which MDMA is used as a treatment adjunct for AUD.
- Describe at least two evidence-based strategies for managing co-occurring MDMA and alcohol use disorders.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 0.5 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 0.50 number of contact hours of which 0.25 are eligible for pharmacology credit.
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Hide details
Past events
Addressing Alcohol and Caffeine Co-Use
Monday, 12/1/25, 12:00 PM – 12:30 PM ET
Virtual event via Zoom
Credits available
This training is designed for healthcare providers managing patients who consume both alcohol and caffeine. Participants will explore evidence-informed strategies to identify individuals at risk and reduce the potential health consequences associated with co-use. The session will also examine policy-level approaches aimed at mitigating risks and supporting safer consumption practices. In addition, participants will review treatment strategies that account for the complexities of concurrent alcohol and caffeine use.
Show details
Virtual meeting
Via Zoom
Description
This training is designed for healthcare providers managing patients who consume both alcohol and caffeine. Participants will explore evidence-informed strategies to identify individuals at risk and reduce the potential health consequences associated with co-use. The session will also examine policy-level approaches aimed at mitigating risks and supporting safer consumption practices. In addition, participants will review treatment strategies that account for the complexities of concurrent alcohol and caffeine use.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Andrea Jodat, DNP, FNP-BC, CARN-AP (she/her)Andrea is a clinical nurse educator for Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance program, a Family Nurse Practitioner in General Internal Medicine at BMC, and an Assistant Professor of Medicine at the Boston University Chobanian & Avedisian School of Medicine. Andrea earned a Doctor of Nursing Practice (DNP) from the Massachusetts General Hospital Institute of Health Professions and is certified as a Certified Addiction Registered Nurse - Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Describe the prevalence and patterns of concurrent alcohol and caffeine consumption.
- Explain at least two physiological or behavioral health risks associated with alcohol mixed with energy drinks (AMED) or caffeinated alcoholic beverages (CAB).
- Identify at least two evidence-informed policy or regulatory strategies aimed at reducing AMED and CAB consumption.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 0.5 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 0.50 number of contact hours of which 0.25 are eligible for pharmacology credit.
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Hide details
Addressing Alcohol and Nicotine Co-Use
Monday, 12/8/25, 12:00 PM – 12:30 PM ET
Virtual event via Zoom
Credits available
This training is designed for healthcare providers who care for patients who consume alcohol, with a focus on identifying individuals at increased risk for adverse health outcomes associated with alcohol and nicotine co-use. Participants will explore practical, evidence-informed strategies to mitigate risks and promote safer patterns of use. The session will also review policy and system-level approaches that support risk reduction and prevention efforts. In addition, participants will examine FDA-approved treatment options and clinical interventions that address the complexities of concurrent alcohol and nicotine use.
Show details
Virtual meeting
Via Zoom
Description
This training is designed for healthcare providers who care for patients who consume alcohol, with a focus on identifying individuals at increased risk for adverse health outcomes associated with alcohol and nicotine co-use. Participants will explore practical, evidence-informed strategies to mitigate risks and promote safer patterns of use. The session will also review policy and system-level approaches that support risk reduction and prevention efforts. In addition, participants will examine FDA-approved treatment options and clinical interventions that address the complexities of concurrent alcohol and nicotine use.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Andrea Jodat, DNP, FNP-BC, CARN-AP (she/her)Andrea is a clinical nurse educator for Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance program, a Family Nurse Practitioner in General Internal Medicine at BMC, and an Assistant Professor of Medicine at the Boston University Chobanian & Avedisian School of Medicine. Andrea earned a Doctor of Nursing Practice (DNP) from the Massachusetts General Hospital Institute of Health Professions and is certified as a Certified Addiction Registered Nurse - Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Describe the prevalence and clinical significance of concurrent nicotine and alcohol use.
- Explain at least two physiological or behavioral health consequences associated with co-use.
- Identify at least two evidence-based treatment strategies for managing co-occurring nicotine and alcohol use disorders.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 0.5 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 0.50 number of contact hours of which 0.25 are eligible for pharmacology credit.
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Hide details
Addressing Alcohol and Cocaine Co-Use
Monday, 12/15/25, 12:00 PM – 12:30 PM ET
Virtual event via Zoom
Credits available
Counts towards DEA's 8-hour training requirement
This training is designed for healthcare providers who manage patients using both alcohol and cocaine. Participants will explore evidence-informed strategies to reduce risks and support safer patterns of use among patients with co-occurring alcohol and cocaine consumption. The session emphasizes the biochemical process of transesterification and the clinical impact of cocaethylene on health outcomes. Participants will also review policy-level approaches that mitigate risks and examine comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and cocaine use disorders.
Show details
Virtual meeting
Via Zoom
Description
This training is designed for healthcare providers who manage patients using both alcohol and cocaine. Participants will explore evidence-informed strategies to reduce risks and support safer patterns of use among patients with co-occurring alcohol and cocaine consumption. The session emphasizes the biochemical process of transesterification and the clinical impact of cocaethylene on health outcomes. Participants will also review policy-level approaches that mitigate risks and examine comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and cocaine use disorders.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Justin Alves, MSN, FNP-BC, ACRN, CARN, CNE (he/him)Justin is a clinical nurse educator with Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistance, a Family Nurse Practitioner in General Internal Medicine at BMC, and co-medical director of BMC’s Stimulant Treatment and Recovery Team (START) clinic. Justin earned a master’s in nursing from the University of Massachusetts-Dartmouth, a Post-Master's Family Nurse Practitioner certificate from the University of Massachusetts-Boston and is certified as a Certified Addiction Registered Nurse through the Addictions Nursing Certification Board.
Objectives
At the end of this training, participants will have the knowledge necessary to:
- Describe the prevalence and clinical relevance of concurrent alcohol and cocaine use.
- Explain at least two physiological or behavioral health risks associated with alcohol and cocaine co-use.
- Identify at least two evidence-based interventions for managing co-occurring alcohol and cocaine use disorders.
- Describe the biochemical process of transesterification leading to the formation of cocaethylene and its clinical implications.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
REQUIREMENTS for credit
- Register for training.
- Arrive/log into the Zoom meeting with the same email address associated with your addictiontraining.org user account no more than 10 minutes after designated start time for program.
- Identify yourself by typing your full name, ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
- Be present through the end of the activity (i.e. until the designated end time of training).
- Complete evaluation within 2 weeks of program completion.
Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.
Joint Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 0.50 AMA PRA Category 0.5 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Nursing Contact Hours: 0.50 number of contact hours of which 0.25 are eligible for pharmacology credit.
LMHC
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 0.50 contact hours will be offered to participants who attend the training and complete the evaluation.
LADC/CADC & Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance is approved by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coaches who complete this training 0.50 continuing education credits.
Disclaimer
Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
Hide details
